Table 3 Concentrations of selected cytokines. Data are expressed as mean ± SD, in case of non-parametric distribution, median (25th - 75th percentile)
From: Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
MS (n = 19) | Controls (n = 19) | |
|---|---|---|
IL-1β (pg/ml) | 2.48 ± 1.08 | 2.23 ± 0.97 |
IL-2 (pg/ml) | 10.55 ± 7.56 | 9.73 ± 7.07 |
IL-4 (pg/ml) | 4.58 ± 1.94 | 4.06 ± 2.40 |
IL-5 (pg/ml) | 9.84 ± 6.13 | 8.20 ± 6.19 |
IL-6 (pg/ml) | 9.51 ± 4.80 | 9.10 ± 6.10 |
IL-7 (pg/ml) | 15.28 ± 8.16 | 14.07 ± 8.44 |
IL-8 (pg/ml) | 30.99 ± 12.92 | 25.76 ± 14.43 |
IL-10 (pg/ml) | 6.00 ± 3.52 | 5.67 ± 3.06 |
IL-12 (pg/ml) | 18.63 ± 12.95 | 16.33 ± 11.69 |
IL-13 (pg/ml) | 15.97 ± 6.77 | 16.59 ± 9.48 |
IL-17 (pg/ml) | 29.06 (24.05–39.17) | 30.30 ± 23.59 |
G-CSF (pg/ml) | 134.7 ± 50.5 | 144.0 ± 79.1 |
GM-CSF (pg/ml) | 23.29 ± 19.75 | 25.97 ± 21.57 |
IFN-γ (pg/ml) | 302 ± 156 | 252 ± 167 |
TNF-α (pg/ml) | 56.89 ± 41.18 | 51.53 ± 38.27 |